Email UpdatesThis two-day public workshop convened regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines.
Source
Duke-Margolis Center for Health Policy / Food and Drug Administration (FDA)
Year
Format
Terms of Use
Topic
Audience
Resource Type
Special Collection